Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Speaking Up For Orphan Drugs

Executive Summary

A colloquy between Sen. Orrin Hatch and HHS Secretary Nominee Tom Price offered a timely rebuttal to a strangely one-sided investigative piece on the Orphan Drug law by Kaiser Health News and NPR.

Advertisement

Related Content

Orphan Pediatric Loophole To Be Closed By US FDA
Time For Big Pharma To Take Back Orphan Drugs
HHS Nominee Price Sidesteps Medicare Drug Pricing Negotiation Questions

Topics

Advertisement
UsernamePublicRestriction

Register

PS119877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel